Ra Pharmaceuticals Inc
(RARX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2016 | 12-2015 | 09-2015 | 12-2014 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | N/A | N/A | N/A | 4,030 |
| Receivables | N/A | N/A | N/A | 70 |
| Other current assets | 0 | 0 | 0 | 340 |
| TOTAL | $N/A | $N/A | $N/A | $4,440 |
| Non-Current Assets | ||||
| PPE Net | N/A | N/A | N/A | 3,590 |
| Other Non-Current Assets | 0 | 0 | 0 | 690 |
| TOTAL | $N/A | $N/A | $N/A | $4,280 |
| Total Assets | $N/A | $N/A | $N/A | $7,310 |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 0 | 0 | 0 | 560 |
| Accrued Expenses | N/A | N/A | N/A | 440 |
| Other current liabilities | N/A | N/A | N/A | 1,790 |
| TOTAL | $N/A | $N/A | $N/A | $2,800 |
| Non-Current Liabilities | ||||
| Other Non-Current Liabilities | 0 | 0 | 0 | 28,980 |
| TOTAL | $N/A | $N/A | $N/A | $30,220 |
| Total Liabilities | $N/A | $N/A | $N/A | $33,020 |
| Shareholders' Equity | ||||
| Retained earnings | N/A | N/A | N/A | -25,950 |
| TOTAL | $N/A | $N/A | $N/A | $-25,710 |
| Total Liabilities And Equity | $0 | $0 | $0 | $7,310 |